Overview Global Non-Invasive Ventilation Masks and Circuits market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031. Non-invasive ventilation masks and circuits help deliver oxygen with accurate pressure delivery. It is a breathing support that is administered through a face mask or nasal mask. The delivery of positive pressure directly into the lungs can be done using NIV masks and circuits without the need for the endotracheal pathway. Market Dynamics: Drivers & Restraints Increasing incidence of respiratory disorders An increase in respiratory diseases is expected to drive the non-invasive ventilation masks and circuits market. The prevalence of respiratory diseases is rising due to the increase in the usage of cigarettes by people. Most middle-aged people are suffering from one or other respiratory disease. For instance, according to the Institute of Health Metrics and Evaluation, 2023, chronic respiratory diseases were the third leading cause of death responsible for 4.0 million deaths. The total deaths and prevalence of CRDs have increased by nearly 28.5% and more than 39.8%. In March 2023, according to the World Health Organization, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Approximately 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC). Complications of NIV masks Non-invasive masks give rise to the development of pressure ulcers over time due to the flow. The oxygen can lead upward to the eye causing eye irritation and conjunctivitis due to ill-fitting of the mask. The flow rates can also intervene in the mobilization of secretions. The above factors are expected to hinder the non-invasive ventilation masks and circuits market. Segment Analysis The global non-invasive ventilation masks and circuits market is segmented based on product type, application end-user and region. Non-invasive ventilation (NIV) masks product type is expected to dominate the market The non-invasive masks segment is expected to hold the largest share of the market due to the increasing clinical trials. The trials are focused on the treatment of respiratory disorders using non-invasive ventilation masks. For instance, according to Clinicaltrials.gov, the Central Denmark Region is conducting clinical trials to determine the efficacy of NIV face masks if treatment with prehospital Non-invasive ventilation (NIV) for patients with acute respiratory failure (ARF) is performed. The estimated study completion date is January 30, 2025. Hospital Universitario 12 de Octubre is conducting clinical trials aim of this study is to investigate the usefulness of a customised mask (non-invasive ventilation) approach to minimise leakage and upper airway obstruction. The estimated study completion is by May 2024. Geographical Analysis North America is Expected to Dominate the Global Market North America is expected to hold the largest share of the market due to the high incidence of asthma and COPD in this region. For instance, according to the Centers for Disease Control and Prevention, 2024, respiratory disease activity in the United States remains high due to the presence of virus traces in some parts of the US. According to the American Lung Association, 2023, Asthma affects 24.8 million Americans, including 5.5 million children. It accounts for millions of hospital visits every year. COPD affects 11.7 million adults in the US which is very high due to cigarette smoking and overlapping respiratory diseases. Market Segmentation By Product Type • NIV Masks • NIV Circuits By Application • Anesthesia • Chronic Obstructive Pulmonary disorders • Cardiogenic pulmonary edema • Pneumonia • Other Respiratory Diseases By End User • Hospitals • Home care settings • Ambulatory Surgical Centers • Long-term care facilities • Others By Region • North America o U.S. o Canada o Mexico • Europe o Germany o UK o France o Italy o Spain o Rest of Europe • South America o Brazil o Argentina o Rest of South America • Asia-Pacific o China o India o Japan o Australia o Rest of Asia-Pacific • Middle East and Africa Key Developments • In July 2023, ReddyPort non-invasive ventilation device received approval from the Food and Drug Administration. • In May 2023, Air Liquide Medical Systems launched a new ALNEST N1 Silent nasal mask that is designed to provide maximum comfort and treat sleep apnea. • In May 2023, Max Ventilator launched multifunctional non-invasive (NIV) ventilators which have inbuilt oxygen therapy and humidifier. Competitive Landscape The major global players in the non-invasive ventilation masks and circuits market include Dragerwerk AG & Co KGaA, Koninklijke Philips NV, Cardinal Health, ResMed, Hamilton Medical, Armstrong Medical Ltd, DEAS S.R.L., SURU INTERNATIONAL PVT. LTD., Medline Industries, Inc., GWS Surgicals LLP among others. Why Purchase the Report? • To visualize the global non-invasive ventilation masks and circuits market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players. • Identify commercial opportunities by analyzing trends and co-development. • Excel data sheet with numerous data points of non-invasive ventilation masks and circuits market-level with all segments. • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study. • Product mapping available as excel consisting of key products of all the major players. The global non-invasive ventilation masks and circuits market report would provide approximately 63 tables, 65 figures and 186 pages. Target Audience 2023 • Manufacturers/ Buyers • Industry Investors/Investment Bankers • Research Professionals • Emerging Companies

1 Methodology and Scope 1.1 Research Methodology 1.2 Research Objective and Scope of the Report 2 Definition and Overview 3 Executive Summary 3.1 Snippet by Product Type 3.2 Snippet by Application 3.3 Snippet by End User 3.4 Snippet by Region 4 Dynamics 4.1 Impacting Factors 4.1.1 Drivers 4.1.1.1 Increasing incidence of respiratory disorders 4.1.1.2 YY 4.1.2 Restraints 4.1.2.1 Complications of NIV masks 4.1.2.2 YY 4.1.3 Opportunity 4.1.4 Impact Analysis 5 Industry Analysis 5.1 Porter's Five Force Analysis 5.2 Supply Chain Analysis 5.3 Pricing Analysis 5.4 Regulatory Analysis 5.5 Reimbursement Analysis 5.6 Patent Analysis 5.7 Pipeline Analysis 5.8 SWOT Analysis 5.9 DMI Opinion 6 COVID-19 Analysis 6.1 Analysis of COVID-19 6.1.1 Scenario Before COVID 6.1.2 Scenario During COVID 6.1.3 Scenario Post COVID 6.2 Pricing Dynamics Amid COVID-19 6.3 Demand-Supply Spectrum 6.4 Government Initiatives Related to the Market During Pandemic 6.5 Manufacturers Strategic Initiatives 6.6 Conclusion 7 By Product Type 7.1 Introduction 7.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type 7.1.2 Market Attractiveness Index, By Product Type 7.2 NIV Masks* 7.2.1 Introduction 7.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%) 7.3 NIV Circuits 8 By Application 8.1 Introduction 8.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 8.1.2 Market Attractiveness Index, By Application 8.2 Anesthesia* 8.2.1 Introduction 8.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%) 8.3 Chronic Obstructive Pulmonary disorders 8.4 Cardiogenic pulmonary edema 8.5 Pneumonia 8.6 Other Respiratory Diseases 9 By End User 9.1 Introduction 9.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 9.1.2 Market Attractiveness Index, By End User 9.2 Hospitals* 9.2.1 Introduction 9.2.2 Market Size Analysis and Y-o-Y Growth Analysis (%) 9.3 Home care settings 9.4 Ambulatory Surgical Centers 9.5 Long-term care facilities 9.6 Others 10 By Region 10.1 Introduction 10.1.1 Market Size Analysis and Y-o-Y Growth Analysis (%), By Region 10.1.2 Market Attractiveness Index, By Region 10.2 North America 10.2.1 Introduction 10.2.2 Key Region-Specific Dynamics 10.2.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type 10.2.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.2.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 10.2.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 10.2.6.1 U.S 10.2.6.2 Canada 10.2.6.3 Mexico 10.3 Europe 10.3.1 Introduction 10.3.2 Key Region-Specific Dynamics 10.3.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type 10.3.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.3.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 10.3.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 10.3.6.1 Germany 10.3.6.2 UK 10.3.6.3 France 10.3.6.4 Italy 10.3.6.5 Spain 10.3.6.6 Rest of Europe 10.4 South America 10.4.1 Introduction 10.4.2 Key Region-Specific Dynamics 10.4.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type 10.4.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.4.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 10.4.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 10.4.6.1 Brazil 10.4.6.2 Argentina 10.4.6.3 Rest of South America 10.5 Asia-Pacific 10.5.1 Introduction 10.5.2 Key Region-Specific Dynamics 10.5.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type 10.5.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.5.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 10.5.6 Market Size Analysis and Y-o-Y Growth Analysis (%), By Country 10.5.6.1 China 10.5.6.2 India 10.5.6.3 Japan 10.5.6.4 Australia 10.5.6.5 Rest of Asia-Pacific 10.6 Middle East and Africa 10.6.1 Introduction 10.6.2 Key Region-Specific Dynamics 10.6.3 Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type 10.6.4 Market Size Analysis and Y-o-Y Growth Analysis (%), By Application 10.6.5 Market Size Analysis and Y-o-Y Growth Analysis (%), By End User 11 Competitive Landscape 11.1 Competitive Scenario 11.2 Market Positioning/Share Analysis 11.3 Mergers and Acquisitions Analysis 12 Company Profiles 12.1 Dragerwerk AG & Co KGaA* 12.1.1 Company Overview 12.1.2 Product Portfolio and Description 12.1.3 Financial Overview 12.1.4 Key Developments 12.2 Koninklijke Philips NV 12.3 Cardinal Health 12.4 ResMed 12.5 Hamilton Medical 12.6 Armstrong Medical Ltd 12.7 DEAS S.R.L 12.8 SURU INTERNATIONAL PVT. LTD 12.9 Medline Industries, Inc 12.10 GWS Surgicals LLP 13 Appendix 13.1 About Us and Services 13.2 Contact Us